Comparison of Prosthetic Assessment Tools and Factors Influencing the Outcome

NCT ID: NCT03329326

Last Updated: 2019-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

73 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-01

Study Completion Date

2019-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background and rational:

A large number of instruments exists to assess upper limb prosthetic function. However, they differ substantially in terms of psychometric properties and content. Furthermore, there is no "gold standard" and nearly every single center uses a unique set of instruments. This fact prevents the linking of the commonly small (due to the limited number of patients in each center) data sets of different centers and makes comparisons between different fittings or treatment protocols difficult. To generate accepted evidence, we need large data sets with similar outcomes. With remarkable progress made in prosthetic research and rehabilitation in the recent years, the need to evaluate the impact of this intervention on daily life, including productivity, self-care and leisure becomes increasingly relevant. Moreover, self-reported instruments and observation-based instruments exist, but there is a lack of data if, for example, the self-reported instrument (which is easier and less health-professional's-time-consuming to perform) could "replace" a performance or observation-based instrument.

Therefore, the aim of this study is to determine psychometric properties of the existing instruments (SHAP, DASH, SF-36 and ACMC) in a large international data set, to explore possible linkage between self-reported and performance or observation-based instruments and to develop state-of-the art recommendations/points to consider on how to assess functioning in prosthetic care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background and rational:

A large number of instruments exists to assess upper limb prosthetic function. However, they differ substantially in terms of psychometric properties and content. Furthermore, there is no "gold standard" and nearly every single center uses a unique set of instruments. This fact prevents the linking of the commonly small (due to the limited number of patients in each center) data sets of different centers and makes comparisons between different fittings or treatment protocols difficult. To generate accepted evidence, we need large data sets with similar outcomes. With remarkable progress made in prosthetic research and rehabilitation in the recent years, the need to evaluate the impact of this intervention on daily life, including productivity, self-care and leisure becomes increasingly relevant. Moreover, self-reported instruments and observation-based instruments exist, but there is a lack of data if, for example, the self-reported instrument (which is easier and less health-professional's-time-consuming to perform) could "replace" a performance or observation-based instrument.

Therefore, the aim of this study is to determine psychometric properties of the existing instruments in a large international data set, to explore possible linkage between self-reported and performance or observation-based instruments and to develop state-of-the art recommendations/points to consider on how to assess functioning in prosthetic care. Projects exploring outcome assessments should have a broad basis and target different patient populations. To be able to generalize the outcome of the study for the European population, this study is planned as a multi-centre study. Also, having a sufficient number of subjects to calculate statistical relationships is otherwise not possible due the limited number of patients being treated at most centers.

Included patients:

* age: 16-85 years
* major uni-lateral amputation of the upper extremity (includes amputation of the hand, forearm, upper arm and at shoulder level)
* normal hand function of the other side (in case of doubt: SHAP score ≥ 95)
* no major neurologic or untreated psychological disorders
* fitted with an active prosthesis (myo, body-powered or hybrid) for at least 6 months

Used Assessments:

* Southampton Hand Assessment Procedure (SHAP): The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test developed to assess the effectiveness of upper limb prostheses. The SHAP is made up of 6 abstract objects and 14 Activities of Daily Living (ADL). Each task is timed by the participant, so there is no interference or reliability on the reaction times of the observer or clinician. The SHAP Index of Function score is used for comparison, which is a number that provides an overall assessment of hand function. SHAP scores do not plateau at 100, instead scores greater than 100 can be achieved if a participant is exceptionally quick at a given task or series of tasks. Scores less than 100 are an indication of how impaired a participant's hand function is. In general, scores between 95 and 105 are considered normal.
* Disabilities of Arm, Shoulder and Hand Questionnaire (DASH): The DASH is a questionnaire, where patients are asked to rate their (bimanual) performance in daily life. It has been validated for use in patients with musculoskeletal diseases and injuries to the arm. A score of 100 indicates the worst and 0 indicates the best hand function.
* Short Form -36 Quality of Life Questionnaire (SF-36): We will use the SF-36 Health Survey 4-week recall version. The questionnaire addresses eight independent subscales: physical functioning, physical role functioning, bodily pain, general health, vitality, social role functioning, emotional role functioning, and mental health. Each subscale ranges from 0 to 100. Based on the subscales, two superior physical and mental component summary scales can be identified. These have mean values of 50 and an SD of 10. A (German) patient with a psychological sum scale of 65 exhibits above average mental health compared with age-matched and sex-matched Germans.
* Open questions concerning demographic data and prosthesis-related questions (\~15): These questions are used to determine further factors that may influence the outcome of self-rated and performance-based tests. They include factors that are already known to influence upper extremity function or perceived disability (e.g rate at amputation, time since amputation, dominant vs. non-dominant hand), as well as factors that may influence the outcome, but were not studied before in sufficient detail (as living alone).
* Assessment of Capacity of Myoelectric control (ACMC): The "Assessment of Capacity for Myoelectric Control" (ACMC) is an observational assessment developed to assess the ability of a prosthesis user to control a myoelectric prosthetic hand. Each item in the ACMC is an observable prosthetic hand movement, such as timing during grasping, or an observable prosthetic hand movement in relation to other body parts, such as uses the prosthesis over the shoulder. The ACMC assesses how skillful a prosthesis hand user performs different prosthetic hand movements when performing a bimanual activity. To perform the ACMC, a two-day training course is required. As not all participating centres have trained professionals, the use of the ACMC is not mandatory.

Data collection:

* As this is a cross-sectional study, all assessments are performed at one point in time (maximum of 2 months in between the different assessments).
* The participating centers can collect all data by themselves and send (anonymized) data sets to the Medical University of Vienna (MUV). Otherwise, they can invite patients and an experienced physical therapist from MUV will visit the center to do the assessments.

Research questions and statistical considerations:

1. To determine psychometric properties of the existing instruments in a large international data set --\> Linkage of data from different centers, psychometric properties; planned analyses: descriptive statistics, correlation, principal components analyses and Rasch analyses
2. To explore possible linkage between self-reported and performance or observation-based instruments. planned analyses: Regression analyses
3. To develop state-of-the art points to consider on how to assess functioning in prosthetic care

Anticipated sample size:

The aim of this study is to get a (representative) sample of the European prosthesis using population, which presents the major the reason for the multi-centre study design. The planned sample size is 100-200 amputees fitted with an active prosthesis. This number should alow proper statistic calculations of the influence of the co-variants, but also be feasible with the number of centres participating.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation Prosthesis User

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Functional tests and self-reported questionnaires

In this observational study no intervention is initiated. Patients included are only assessed with the non-invasive tests described earlier.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age: 16-85 years
* major uni-lateral amputation of the upper extremity
* normal hand function of the other side (in case of doubt: SHAP score ≥ 95)
* fitted with an active prosthesis for at least 6 months
* gives informed consent

Exclusion Criteria

* major neurologic or untreated psychological disorders
Minimum Eligible Age

16 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center Goettingen

OTHER

Sponsor Role collaborator

Lund University

OTHER

Sponsor Role collaborator

Örebro University, Sweden

OTHER

Sponsor Role collaborator

Helsinki University Central Hospital

OTHER

Sponsor Role collaborator

BG Trauma Center Ludwigshafen

OTHER

Sponsor Role collaborator

Sykehuset Innlandet HF

OTHER

Sponsor Role collaborator

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Agnes Sturma

BSc, MSc

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Agnes BM Sturma, BSc. MSc.

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Helsiniki University Central Hospital

Helsinki, Helsiniki, Finland

Site Status

University Medical Center Goettingen

Goettigen, Lower Saxony, Germany

Site Status

BG Trauma Center Ludwigshafen

Ludwigshafen am Rhein, Rhineland-Palatinate, Germany

Site Status

Sykehuset Innlandet HF

Ottestad, , Norway

Site Status

Lund University

Lund, Skåne County, Sweden

Site Status

Örebro University

Örebro, Örebro County, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Finland Germany Norway Sweden

Related Links

Access external resources that provide additional context or updates about the study.

http://www.dash.iwh.on.ca/

Further information about the DASH

http://www.shap.ecs.soton.ac.uk/

Further information about the SHAP

http://acmc.se/

Further information about the ACMC

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1713/2016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.